Supreme Court Declines Apotex Appeal Of Plavix Suit

Law360, New York (November 2, 2009, 5:37 PM EST) -- Apotex Inc.'s legal dispute with Sanofi-Aventis over blood-thinning drug Plavix has hit a dead end, with the U.S. Supreme Court refusing to hear the generic-drug maker's arguments over whether substances produced by so-called obvious-to-try experiments should be patentable.

The Supreme Court denied Apotex's petition for a writ of certiorari Monday, the last in a string of decisions against Apotex in the dispute.

Sanofi sued Apotex in 2002, shortly after the generics maker filed an abbreviated new drug application to market clopidogrel bisulfate, sold by Sanofi and...
To view the full article, register now.